On 17 February 2023, Germany deposited its instrument of ratification of the Unified Patent Court Agreement (UPCA) with the Council of the European Union (EU). The Unified Patent Court (UPC) will therefore start on 01 June...more
At a recent campaign stop, President Trump informed supporters that he “felt like Superman” after his experimental COVID-19 treatment with a Regeneron Pharmaceuticals Inc. antiviral drug.
The antiviral drug may have resulted...more
10/30/2020
/ Coronavirus/COVID-19 ,
Enablement Inquiries ,
EU ,
European Patent Office ,
Life Sciences ,
Patent Infringement ,
Patent Invalidity ,
Patent Validity ,
Patented Medicines ,
Pharmaceutical Patents ,
Popular ,
Regenerative Medicine ,
Regeneron ,
UK ,
UK Supreme Court